Stock Screener App

Frei -

Installieren

427.00

3.19% 14.65

Madrigal Pharmaceuticals Inc (MDGL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MDGL? Forum Prognose Aktiensplit

Finanzdaten der Madrigal Pharmaceuticals Inc-Aktie (MDGL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	55.05% 212.80	137.25	103.32	62.17	14.64
Operating Expenses	20.06% 260.00	216.56	164.08	178.48	177.18
Benefits Costs and Expenses	100.00% -	210.49	162.74	-	-
Costs And Expenses	23.52% 260.00	210.49	194.72	178.48	177.18
Operating Income/Loss	40.48% -47.20	-79.31	-67.00	-116.30	-162.54
Income/Loss From Continuing Operations Before Tax	390.56% 212.80	-73.24	-59.42	62.17	-151.97
Income/Loss From Continuing Operations After Tax	42.27% -42.28	-73.24	-59.42	-106.96	-151.97
Net Income/Loss	42.27% -42.28	-73.24	-59.42	-106.96	-151.97
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.52% 22.21	22.09	0.2204	21.75	21.40
Diluted Average Shares	0.52% 22.21	22.09	0.2204	21.75	21.40
Basic Earnings Per Share	42.77% -1.90	-3.32	-2.59	-4.92	-7.10
Diluted Earnings Per Share	42.77% -1.90	-3.32	-2.59	-4.92	-7.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.41

0.51%

GMAB

$28.83

0.42%

INCY

$100.47

1.20%

BNTX

$103.85

0.08%

ONC

$310.01

0.52%

INSM

$184.61

0.50%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters